BMP2 and hyperphosphatemia: Hyperphosphatemia activates multiple signaling pathways, including NF-κB, Wnt/β-catenin, and BMP-2/Smad, inducing osteogenic phenotypic transformation of vascular smooth muscle cells (VSMCs) [23].